Spatial analysis reveals significant rcn interactions and differences in genetic subtypes of DLBCL.
The relation between RCNs and LME subtypes and DLBCL genetic subtypes based on LymphGen classification and driver mutations (n = 85). A, A heatmap depicting the average proportions of RCNs in the different LME subtypes. B, A boxplot depicting the median proportion of cells with an immune-poor RCN5 neighborhood in depleted (DP) DLBCLs compared with GC-like (GC), mesenchymal (MS), and inflamed (IN) DLBCLs. The groups were compared using Mann–Whitney U test. C, A boxplot depicting the median proportion of cells with a PD-L1⁺ M2-like TAM-rich RCN10 neighborhood in inflamed DLBCLs compared with GC-like, mesenchymal, and depleted DLBCLs. The groups were compared using Mann–Whitney U test. D, Oncoprint of selected mutations and proportions of RCNs in DLBCL genetic subtypes. E, A boxplot depicting the median proportion of cells with a PD-L1⁺ M2-like TAM-rich RCN10 neighborhood in different genetic subtypes. The groups were compared using Kruskal–Wallis H test. F, A boxplot depicting the median proportion of cells with a PD-L1⁺ B cell–rich RCN7 neighborhood in different genetic subtypes. The groups were compared using Kruskal–Wallis H test. G, A boxplot depicting the median proportion of cells with a B cell–rich and immune cell–rich RCN1 neighborhood in DLBCLs with and without GNA13 mutations. The groups were compared using Mann–Whitney U test. H, A boxplot depicting the median proportion of cells with a M1-like TAM-rich RCN8 neighborhood in DLBCLs with and without PRDM1 mutations. The groups were compared using Mann–Whitney U test. Lower and upper hinges of the boxplots correspond to the 25th and 75th percentiles, and whiskers to the confidence intervals 1.5 × IQR from the hinge.
No takes yet. Share an insight, caveat, or question.
Autio et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: